U.S. market Closed. Opens in 1 day 9 hours 38 minutes

RIBT | RiceBran Technologies Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.0003 - 0.0003
52 Week Range 0.0002 - 0.2700
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 6
Average Volume 10,684
Shares Outstanding 10,004,000
Market Cap 3,001
Sector Consumer Defensive
Industry Packaged Foods
IPO Date 2003-10-01
Valuation
Profitability
Growth
Health
P/E Ratio N/A
Forward P/E Ratio N/A
EPS -1.19
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 35
Country USA
Website RIBT
RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. Its SRB and derivative products are nutritional and beneficial food products that contain a combination of oil, protein, carbohydrates, vitamins, minerals, fibers, and antioxidants that enhance the nutritional value of consumer products. The company's SRB products are also marketed as feed ingredients in the animal nutrition markets. It serves food and animal nutrition manufacturers, wholesalers, and retailers in the United States and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.
RIBT's peers: BTTR, BSFC, BTOG, FAMI, LSF, RKDA, SNAX, NCRA, STKH
*Chart delayed
Analyzing fundamentals for RIBT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see RIBT Fundamentals page.

Watching at RIBT technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on RIBT Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙